- CA$27.77m
- CA$18.34m
- CA$45.12m
Brief: Medipharm Labs Improves Domestic Sales Gross Margin With Termination Of Shelter Cannabis Brands Royalty Agreement
Brief: MediPharm Labs Makes First Delivery Of Cannabis Clinical Trial Material To Us Research Partner, Provides Update On US FDA Status
Brief: Medipharm Labs Reports First Quarter Results With Growth In Sales, Margin And EBITDA
Brief: MediPharm Labs Provides Update On Vivo Integration, Board Appointee
Brief: MediPharm Labs Reports Fourth Quarter And Full Year 2022 Results
Brief: Medipharm Labs Corp. Announces Mailing And Filing Of Joint Circular For Special Meeting Of Shareholders To Approve Arrangement With Vivo Cannabis Inc.
VIVO Cannabis sinks after buyout offer from MediPharm Labs
Brief: Medipharm Labs Corp To Acquire Vivo Cannabis Inc
Brief: Medipharm Labs Reports Third Quarter Results
Brief: Medipharm Labs Reports Third Quarter Results
Brief: Medipharm Labs Reports Second Quarter Results
Brief: MediPharm Labs Enters Cannabis Research Agreement With Keck School Of Medicine Of USC
Brief: Medipharm Labs Awarded Payment Of $9.8 Mln In Connection To A 2020 Statement Of Claim Against A Previous Customer
Brief: Medipharm Labs Enters Into $6.2 Mln Purchase Agreement For Sale Of Australian Facility
Brief: Medipharm Labs Reports First Quarter Results
Brief: Medipharm Labs Names Experienced Pharma And Med Tech Executive David Pidduck, As CEO
Brief: Medipharm Labs Appointed David Pidduck As Chief Executive Officer And Director Of Company
Canada Research Roundup: BRP, Endeavour Mining, Well Health Technologies
Brief: Medipharm Labs Reports Fourth Quarter And Full Year 2021 Results